🔗 Share this article

Texas Attorney General Ken Paxton is suing the producers of Tylenol, claiming the companies concealed alleged dangers that the medication presented to children's brain development.

The court filing follows a month after Former President Trump advocated an unproven link between consuming Tylenol - referred to as paracetamol - throughout gestation and autism in children.

The attorney general is taking legal action against the pharmaceutical giant, which once produced the medication, the sole analgesic approved for expectant mothers, and Kenvue, which currently produces it.

In a statement, he stated they "betrayed America by gaining financially from discomfort and marketing drugs ignoring the dangers."

Kenvue says there is lacking scientific proof connecting Tylenol to autism.

"These corporations deceived for years, knowingly endangering numerous people to line their pockets," Paxton, a Republican, stated.

The manufacturer stated officially that it was "deeply concerned by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the health of women and children in America."

On its website, the company also said it had "regularly reviewed the applicable studies and there is no credible data that demonstrates a proven link between using paracetamol and autism."

Associations acting on behalf of physicians and medical practitioners share this view.

ACOG has declared acetaminophen - the key substance in Tylenol - is one of the few options for expectant mothers to manage discomfort and fever, which can present significant medical dangers if ignored.

"In more than two decades of studies on the consumption of paracetamol in pregnancy, no reliable research has conclusively proven that the consumption of acetaminophen in any stage of gestation leads to neurodevelopmental disorders in young ones," the organization stated.

The court filing cites recent announcements from the Trump administration in arguing the medication is reportedly hazardous.

Last month, the former president raised alarms from medical authorities when he instructed expectant mothers to "struggle intensely" not to use acetaminophen when sick.

Federal regulators then published an announcement that physicians should contemplate reducing the consumption of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism in young ones has not been proven.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had promised in spring to conduct "comprehensive study program" that would determine the source of autism in a short period.

But experts warned that identifying a sole reason of autism spectrum disorder - believed by scientists to be the consequence of a intricate combination of genetic and environmental factors - would be difficult.

Autism spectrum disorder is a form of lifelong neurodivergence and disability that impacts how persons experience and relate to the environment, and is identified using medical professional evaluations.

In his legal document, Paxton - aligned with the former president who is campaigning for federal office - claims Kenvue and J&J "intentionally overlooked and sought to suppress the science" around acetaminophen and autism spectrum disorder.

The case attempts to require the corporations "eliminate any promotional materials" that claims Tylenol is secure for expectant mothers.

This legal action mirrors the complaints of a group of mothers and fathers of children with autism and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in 2022.

A federal judge dismissed the case, stating investigations from the family's specialists was inconclusive.